OBJECTIVE: Compare the severity of illnesses associated with influenza and noninfluenza acute respiratory illness (ARI) in healthcare personnel (HCP). DESIGN: Prospective observational cohort. PARTICIPANTS: HCP at 2 healthcare organizations with direct patient contact were enrolled prior to the 2010-2011 influenza season. METHODS: HCP who were fewer than 8 days from the start of fever/feverishness/chills and cough were eligible for real-time reverse-transcription polymerase chain reaction influenza virus testing of respiratory specimen. Illness severity was assessed by the sum of self-rated severity (0, absent; 3, severe) of 12 illness symptoms, subjective health (0, best health; 9, worst health), activities of daily living impairment (0, able to perform; 9, unable to perform), missed work, and duration of illness. RESULTS: Of 1,701 HCP enrolled, 267 were tested for influenza, and 58 (22%) of these tested positive. Influenza compared with noninfluenza illnesses was associated with higher summed 12-symptom severity score (mean [standard deviation], 17.9 [5.4] vs 14.6 [4.8]; P < .001), worse subjective health (4.5 [1.8] vs 4.0 [1.8]; P <.05), greater impairment of activities of daily living (4.9 [2.5] vs 3.8 [2.5]; P < .01), and more missed work (12.1 [10.5] vs 7.8 [10.5] hours; P < .01). Differences in symptom severity, activities of daily living, and missed work remained significant after adjusting for illness and participant characteristics. CONCLUSIONS: Influenza had a greater negative impact on HCP than noninfluenza ARIs, indicated by higher symptom severity scores, less ability to perform activities of daily living, and more missed work. These results highlight the importance of efforts to prevent influenza infection in HCP.
OBJECTIVE: Compare the severity of illnesses associated with influenza and noninfluenza acute respiratory illness (ARI) in healthcare personnel (HCP). DESIGN: Prospective observational cohort. PARTICIPANTS: HCP at 2 healthcare organizations with direct patient contact were enrolled prior to the 2010-2011 influenza season. METHODS: HCP who were fewer than 8 days from the start of fever/feverishness/chills and cough were eligible for real-time reverse-transcription polymerase chain reaction influenza virus testing of respiratory specimen. Illness severity was assessed by the sum of self-rated severity (0, absent; 3, severe) of 12 illness symptoms, subjective health (0, best health; 9, worst health), activities of daily living impairment (0, able to perform; 9, unable to perform), missed work, and duration of illness. RESULTS: Of 1,701 HCP enrolled, 267 were tested for influenza, and 58 (22%) of these tested positive. Influenza compared with noninfluenza illnesses was associated with higher summed 12-symptom severity score (mean [standard deviation], 17.9 [5.4] vs 14.6 [4.8]; P < .001), worse subjective health (4.5 [1.8] vs 4.0 [1.8]; P <.05), greater impairment of activities of daily living (4.9 [2.5] vs 3.8 [2.5]; P < .01), and more missed work (12.1 [10.5] vs 7.8 [10.5] hours; P < .01). Differences in symptom severity, activities of daily living, and missed work remained significant after adjusting for illness and participant characteristics. CONCLUSIONS:Influenza had a greater negative impact on HCP than noninfluenza ARIs, indicated by higher symptom severity scores, less ability to perform activities of daily living, and more missed work. These results highlight the importance of efforts to prevent influenza infection in HCP.
Authors: Fiona Havers; Swathi Thaker; Jessie R Clippard; Michael Jackson; Huong Q McLean; Manjusha Gaglani; Arnold S Monto; Richard K Zimmerman; Lisa Jackson; Josh G Petrie; Mary Patricia Nowalk; Krissy K Moehling; Brendan Flannery; Mark G Thompson; Alicia M Fry Journal: Clin Infect Dis Date: 2014-07-16 Impact factor: 9.079
Authors: Robert G Deiss; John C Arnold; Wei-Ju Chen; Sara Echols; Mary P Fairchok; Christina Schofield; Patrick J Danaher; Erin McDonough; Michelande Ridoré; Deepika Mor; Timothy H Burgess; Eugene V Millar Journal: Vaccine Date: 2015-11-10 Impact factor: 3.641
Authors: Mark G Thompson; Allison Naleway; Alicia M Fry; Sarah Ball; Sarah M Spencer; Sue Reynolds; Sam Bozeman; Min Levine; Jacqueline M Katz; Manjusha Gaglani Journal: Vaccine Date: 2016-02-10 Impact factor: 3.641
Authors: Mark G Thompson; Jeannette R Ferber; Roxana Odouli; Donna David; Pat Shifflett; Jennifer K Meece; Allison L Naleway; Sam Bozeman; Sarah M Spencer; Alicia M Fry; De-Kun Li Journal: Influenza Other Respir Viruses Date: 2015-05 Impact factor: 4.380
Authors: Avital Hirsch; Mark A Katz; Alon Laufer Peretz; David Greenberg; Rachael Wendlandt; Yonat Shemer Avni; Gabriella Newes-Adeyi; Ilan Gofer; Maya Leventer-Roberts; Nadav Davidovitch; Anat Rosenthal; Rachel Gur-Arie; Tomer Hertz; Aharona Glatman-Freedman; Arnold S Monto; Eduardo Azziz-Baumgartner; Jill Morris Ferdinands; Emily Toth Martin; Ryan E Malosh; Joan Manuel Neyra Quijandría; Min Levine; William Campbell; Ran Balicer; Mark G Thompson Journal: BMC Infect Dis Date: 2018-11-06 Impact factor: 3.090
Authors: Michael Hinojosa; Samuel S Shepard; Jessie R Chung; Jennifer P King; Huong Q McLean; Brendan Flannery; Edward A Belongia; Min Z Levine Journal: J Infect Dis Date: 2021-08-02 Impact factor: 5.226
Authors: Meredith G Wesley; Giselle Soto; Carmen Sofia Arriola; Miriam Gonzales; Gabriella Newes-Adeyi; Candice Romero; Vic Veguilla; Min Z Levine; Maria Silva; Jill M Ferdinands; Fatimah S Dawood; Sue B Reynolds; Avital Hirsch; Mark Katz; Eduardo Matos; Eduardo Ticona; Juan Castro; Maria Castillo; Eduar Bravo; Angela Cheung; Rachel Phadnis; Emily Toth Martin; Yeny Tinoco; Joan Manuel Neyra Quijandria; Eduardo Azziz-Baumgartner; Mark G Thompson Journal: Influenza Other Respir Viruses Date: 2020-04-05 Impact factor: 4.380